Ma. Van Agtmael et al., Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria, INT J ANT A, 12(2), 1999, pp. 151-158
Multiple dose pharmacokinetics of artemether and dihydroartemisinin were in
vestigated in chinese patients treated for malaria. They received over 2 da
ys either 4 x 80 mg artemether orally (n = 48) or 4 x 80-480 mg co-artemeth
er (n = 40), a combination of artemether and lumefantrine (benflumetol). La
g time = 0.48 h (mean), C-max after first dose = 157 ng/ml, t(max) = 1.73 h
and elimination half-life = 1.16 h. The lag and absorption times were 0.5
h longer for co-artemether compared with artemether. Dihydroartemisinin par
alleled artemether pharmacokinetics. Artemether C-max after the last dose w
as one-third of the C-max after the first dose while, inversely, dihydroart
emisinin C-max increased over time. We suggest that auto-induction of gut m
ucosa enzymes and/or liver enzymes causes a time-dependent increase in firs
t-pass metabolisation of artemether. (C) 1999 Elsevier Science B.V. and Int
ernational Society of Chemotherapy. All rights reserved.